BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32985354)

  • 1. An Integrated Analysis of mRNAs and miRNAs Microarray Profiles to Screen miRNA Signatures Involved in Nasopharyngeal Carcinoma.
    Liu L; Wang H; Yan C; Tao S
    Technol Cancer Res Treat; 2020; 19():1533033820956998. PubMed ID: 32985354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA-Associated ceRNA Network Reveals Novel Potential Biomarkers of Laryngeal Squamous Cell Carcinoma.
    Jing Z; Guo S; Zhang P; Liang Z
    Technol Cancer Res Treat; 2020; 19():1533033820985787. PubMed ID: 33371795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
    Liu M; Zhu K; Qian X; Li W
    Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
    BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
    Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
    Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.
    Luo Z; Zhang L; Li Z; Li X; Li G; Yu H; Jiang C; Dai Y; Guo X; Xiang J; Li G
    BMC Med Genomics; 2012 Jan; 5():3. PubMed ID: 22260379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
    Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
    Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYC and hsa‑miRNA‑423‑5p as biomarkers in nasopharyngeal carcinoma revealed by miRNA‑mRNA‑pathway network integrated analysis.
    Tian H; Chen S; Zhang C; Li M; Zheng H
    Mol Med Rep; 2017 Aug; 16(2):1039-1046. PubMed ID: 28586063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA and mRNA Integration Network Construction Reveals Novel Key Regulators in Left-Sided and Right-Sided Colon Adenocarcinoma.
    Yang L; Li L; Ma J; Yang S; Zou C; Yu X
    Biomed Res Int; 2019; 2019():7149296. PubMed ID: 31073530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
    Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
    Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
    J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Differentially Expressed miRNAs and mRNAs in Vestibular Schwannoma by Integrated Analysis.
    Lei Y; Guo P; Li X; Zhang Y; Du T
    Biomed Res Int; 2019; 2019():7267816. PubMed ID: 31309113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
    Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
    Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma.
    Wu L; Zheng K; Yan C; Pan X; Liu Y; Liu J; Wang F; Guo W; He X; Li J; Shen Y
    BMC Cancer; 2019 Aug; 19(1):843. PubMed ID: 31455274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate pathways and genes for nasopharyngeal carcinoma based on bioinformatics study.
    Chen J; Yang R; Zhang W; Wang Y
    Int J Clin Exp Pathol; 2015; 8(2):2026-32. PubMed ID: 25973099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome sequencing and miRNA-mRNA network construction in exosome of macrophage M2 in stomach adenocarcinoma.
    Pan D; Li Z; Lin X; Li L
    World J Surg Oncol; 2023 Jun; 21(1):193. PubMed ID: 37370118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.
    Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F
    Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma.
    Gong Z; Yang Q; Zeng Z; Zhang W; Li X; Zu X; Deng H; Chen P; Liao Q; Xiang B; Zhou M; Li X; Li Y; Xiong W; Li G
    Tumour Biol; 2016 Mar; 37(3):3683-95. PubMed ID: 26462838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integration analysis of mRNAs and miRNAs microarray data to identify key regulators for ovarian endometriosis based on competing endogenous RNAs.
    Wang K; Sun Y; Wang Y; Liu L
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():468-475. PubMed ID: 32738676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.